TheEdgeResearch
Home / Stocks / PCNT

Point of Care Nano-Technology, Inc. (PCNT)

OTC Healthcare Biotechnology
$0.01 ▼ -90.00%
Market Cap
$727,906
Sector
Healthcare
Industry
Biotechnology
Beta
0.82
52-Wk Range
0.01-0.01
CEO
Raouf Guirguis
Country
US
Currency
USD

Point of Care Nano-Technology, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Davenport, FL, US. The stock last traded at $0.01, down 90.00% on the session, giving a market capitalisation of $727,906. On trailing twelve-month figures it carries a trailing P/E of -0.10, a net margin of 0.0%. Its beta of 0.82 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.10
Price / Sales
0.00
Price / Book
-0.45
EV / EBITDA
-9.91
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
0.00
Current ratio
0.04
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
IPO date
2012-02-07
Headquarters
Davenport, FL, US
About Point of Care Nano-Technology, Inc.

Point of Care Nano-Technology, Inc. presently has no substantial business operations. However, the company is actively seeking new opportunities within the life sciences sector. Historically, its focus involved the creation and production of medical diagnostic products that utilized saliva. The firm was established in 2010, based in Davenport, Florida, and adopted its current name, Point of Care Nano-Technology, Inc., in March 2015, having previously been known as Unique Growing Solutions, Inc.

Comparable companies

Point of Care Nano-Technology, Inc. is most often compared with the following Healthcare names:

ALSECNBIELVAYGNOWHCYTDNBGVPRXTFSEPSFSPLIFSUVZ
More research on PCNT
PCNT technical analysis PCNT TheEdge Score Compare against peers
Open full interactive analysis & DCF →